Junaid Siddiqui, MD, details the four primary atypical parkinsonian disorders - PSP, MSA, DLB and CBD - and shares effective diagnostic techniques and management strategies, distinguishing them from Parkinson's disease.

Dan Ontaneda, MD, PhD, details the 2024 changes to the McDonald Criteria for multiple sclerosis diagnosis and discusses how these changes may impact and evolve the field.

Imad Najm, MD, explores why temporal lobe epilepsy is among the most challenging epilepsy types to treat and how gene therapy aims to overcome the challenges.

Amanda Horrigan, MD, provides guidance on diagnosing and managing schizophrenia through an empathetic and supportive approach.

Neuroendocrinologist, Divya Yogi-Morren, MD, and neurosurgeon, Pablo Recinos, MD detail the diagnostic work-up, medical management and surgical approaches used in pituitary disorders.

Alison Stout, DO, discusses the diagnostic complexity of axial lumbar back pain and the interventional treatment options currently available.

Amy Kunchok, MD, PhD, discusses the current diagnostic tools and treatment approaches for myelin oligodendrocyte glycoprotein antibody disease (MOGAD).

Yuebing Li, MD, PhD, explores the diagnostic and treatment landscape for generalized and atypical myasthenia gravis.